BioGaia
105.20 SEK
-3.49 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-3.49 %
-6.49 %
-0.94 %
+5.20 %
+11.68 %
-17.88 %
+3.44 %
+17.28 %
+1,381.00 %
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Read moreMarket cap
10.64B SEK
Turnover
45.86M SEK
Revenue
1.42B
EBIT %
29.76 %
P/E
30.23
Dividend yield-%
6.56 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/2
2026
Annual report '25
7/5
2026
General meeting '26
7/5
2026
Interim report Q1'26
All
Webcasts
Press releases
ShowingAll content types
BioGaias resultat för fjärde kvartalet överstiger marknadens förväntningar
BioGaia, Audiocast, Q4'25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
